S Shane

1.4k total citations
15 papers, 1.2k citations indexed

About

S Shane is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, S Shane has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Public Health, Environmental and Occupational Health and 4 papers in Hematology. Recurrent topics in S Shane's work include Acute Lymphoblastic Leukemia research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S Shane is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S Shane collaborates with scholars based in United States. S Shane's co-authors include G Rovera, Robert Wasserman, B A Reichard, A J Caton, Masao Yamada, Naomi Galili, Masayasu Yamada, Yoshihide Tsujimoto, Beverly J. Lange and William M. Nauseef and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

S Shane

15 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
S Shane	517	409	355	342	251	15	1.2k
Winston Verbi	696 1.3×	251 0.6×	197 0.6×	353 1.0×	244 1.0×	17	1.2k
PC Nowell	327 0.6×	352 0.9×	130 0.4×	339 1.0×	244 1.0×	27	1.0k
RW Schroff	444 0.9×	275 0.7×	180 0.5×	204 0.6×	359 1.4×	9	965
D Mathieu-Mahul	519 1.0×	369 0.9×	259 0.7×	742 2.2×	175 0.7×	47	1.5k
Cécile Tonnelle	1.0k 2.0×	523 1.3×	186 0.5×	559 1.6×	251 1.0×	55	1.9k
FJ Bollum	285 0.6×	385 0.9×	345 1.0×	231 0.7×	172 0.7×	13	904
E Tatsumi	685 1.3×	313 0.8×	170 0.5×	639 1.9×	287 1.1×	82	1.8k
Y Takihara	635 1.2×	169 0.4×	127 0.4×	298 0.9×	140 0.6×	35	1.1k
Susan L. Melvin	280 0.5×	758 1.9×	671 1.9×	307 0.9×	222 0.9×	33	1.3k
C. R. Barker	506 1.0×	142 0.3×	83 0.2×	318 0.9×	378 1.5×	39	1.1k

Countries citing papers authored by S Shane

Since Specialization

Citations

This map shows the geographic impact of S Shane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Shane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Shane more than expected).

Fields of papers citing papers by S Shane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Shane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Shane. The network helps show where S Shane may publish in the future.

Co-authorship network of co-authors of S Shane

This figure shows the co-authorship network connecting the top 25 collaborators of S Shane. A scholar is included among the top collaborators of S Shane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Shane. S Shane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Kowalczyk, Dariusz, Anthony P Wlazlo, S Shane, & Hildegund C.J. Ertl. (2001). Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16. Vaccine. 19(25-26). 3583–3590. 25 indexed citations

2.

Wasserman, Robert, Naomi Galili, B A Reichard, et al.. (1993). Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia.. Journal of Clinical Oncology. 11(3). 546–553. 45 indexed citations

3.

Wasserman, Robert, et al.. (1993). Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia.. PubMed. 7(8). 1294–9. 7 indexed citations

4.

Wasserman, Robert, Yoshiaki Ito, Naomi Galili, et al.. (1992). The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stage. The Journal of Immunology. 149(2). 511–516. 28 indexed citations

5.

Wasserman, Robert, Naomi Galili, Yoshiaki Ito, et al.. (1992). Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event.. The Journal of Experimental Medicine. 176(6). 1577–1581. 65 indexed citations

6.

Wasserman, Robert, Naomi Galili, Jeffrey H. Silber, et al.. (1992). Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.. Journal of Clinical Oncology. 10(12). 1879–1888. 80 indexed citations

7.

Wasserman, Robert, et al.. (1992). VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia [see comments]. Blood. 79(1). 223–228. 1 indexed citations

8.

Wasserman, Robert, et al.. (1992). VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia [see comments]. Blood. 79(1). 223–228. 99 indexed citations

9.

Yamada, Masao, Robert Wasserman, B A Reichard, et al.. (1991). Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes.. The Journal of Experimental Medicine. 173(2). 395–407. 333 indexed citations

10.

Johnson, Keith, et al.. (1989). Complete nucleotide sequence of the human myeloperoxidase gene. Nucleic Acids Research. 17(19). 7985–7986. 30 indexed citations

11.

Yamada, Masayasu, et al.. (1989). Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.. Proceedings of the National Academy of Sciences. 86(13). 5123–5127. 235 indexed citations

12.

Tweardy, David J., Linda A. Cannizzaro, Antônio Palumbo, et al.. (1987). Molecular cloning and characterization of a cDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21.. PubMed. 1(3). 209–20. 31 indexed citations

13.

Johnson, Keith R., William M. Nauseef, Alessandra Carè, et al.. (1987). Characterization of cDNA clones for human myeloperoxidase: Predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Research. 15(5). 2013–2028. 147 indexed citations

14.

Palumbo, Antônio, Masaharu Isobe, Kay Huebner, et al.. (1986). Chromosomal localization of a human band 3-like gene to region 7q35----7q36.. PubMed. 39(3). 307–16. 16 indexed citations

15.

Curtis, Peter J., Antônio Palumbo, Jeffrey E. Ming, et al.. (1985). Sequence comparison of human and murine erythrocyte alpha-spectrin cDNA. Gene. 36(3). 357–362. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact